Amicus Therapeutics Overview
Amicus Therapeutics Target Price
Analysts' 12-month price predictions for FOLD.
Share Price
$6.08
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-10-17 | Bank of America SecuritiesTazeen Ahmad | $15 |  146.7% upside |  |
| 2024-05-14 | GuggenheimDebjit Chattopadhyay | $13 | 113.8% upside | |
| 2024-05-09 | Morgan StanleyJeffrey Hung | $19 | 212.5% upside | |
| 2023-12-19 | Morgan StanleyJeffrey Hung | $20 | 228.9% upside | |
| 2021-05-10 | Goldman SachsSalveen Richter | $14 | 130.3% upside | |